BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16979380)

  • 1. Long-acting beta-agonists in adult asthma: Evidence that these drugs are safe.
    Nelson HS
    Prim Care Respir J; 2006 Oct; 15(5):271-7. PubMed ID: 16979380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of regular use of long-acting beta agonists as monotherapy or added to inhaled corticosteroids in asthma. A systematic review.
    Rodrigo GJ; Moral VP; Marcos LG; Castro-Rodriguez JA
    Pulm Pharmacol Ther; 2009 Feb; 22(1):9-19. PubMed ID: 19026757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Fowler SJ; Lipworth BJ
    JAMA; 2001 Dec; 286(24):3076-7; author reply 3077-8. PubMed ID: 11754665
    [No Abstract]   [Full Text] [Related]  

  • 5. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Miller FG; Shorr AF
    JAMA; 2001 Dec; 286(24):3075-6; author reply 3077-8. PubMed ID: 11754663
    [No Abstract]   [Full Text] [Related]  

  • 6. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Friedman Ross L
    JAMA; 2001 Dec; 286(24):3076; author reply 3077-8. PubMed ID: 11754664
    [No Abstract]   [Full Text] [Related]  

  • 7. Salmeterol and inhaled corticosteroids in patients with persistent asthma.
    Botkin JR; Clayton E; Nelson R; Wilfond B; Munger MA
    JAMA; 2001 Dec; 286(24):3075; author reply 3077-8. PubMed ID: 11754662
    [No Abstract]   [Full Text] [Related]  

  • 8. Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events.
    Bateman E; Nelson H; Bousquet J; Kral K; Sutton L; Ortega H; Yancey S
    Ann Intern Med; 2008 Jul; 149(1):33-42. PubMed ID: 18523132
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination therapy with inhaled long-acting beta2-agonists and inhaled corticosteroids: a paradigm shift in asthma management.
    Stoloff S; Poinsett-Holmes K; Dorinsky PM
    Pharmacotherapy; 2002 Feb; 22(2):212-26. PubMed ID: 11837559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mono- and combination therapy of long-acting bronchodilators and inhaled corticosteroids in advanced COPD.
    Ohar JA; Donohue JF
    Semin Respir Crit Care Med; 2010 Jun; 31(3):321-33. PubMed ID: 20496301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.
    Vermetten FA; Boermans AJ; Luiten WD; Mulder PG; Vermue NA
    J Asthma; 1999; 36(1):97-106. PubMed ID: 10077139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of salmeterol and fluticasone propionate alone and in combination on airway blood flow in patients with asthma.
    Mendes ES; Rebolledo P; Wanner A
    Chest; 2012 May; 141(5):1184-1189. PubMed ID: 21980058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial.
    Lazarus SC; Boushey HA; Fahy JV; Chinchilli VM; Lemanske RF; Sorkness CA; Kraft M; Fish JE; Peters SP; Craig T; Drazen JM; Ford JG; Israel E; Martin RJ; Mauger EA; Nachman SA; Spahn JD; Szefler SJ;
    JAMA; 2001 May 23-30; 285(20):2583-93. PubMed ID: 11368732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects on resource utilization of adding salmeterol in combination or separately to inhaled corticosteroids.
    Chan J; Hui RL; Spence MM
    J Manag Care Pharm; 2007; 13(1):21-7. PubMed ID: 17269833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Combination treatment with inhaled corticosteroid/long-acting beta 2-adrenergic bronchodilator in the treatment of asthma].
    Kimura T; Adachi M
    Nihon Rinsho; 2001 Oct; 59(10):1992-9. PubMed ID: 11676144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HelpDesk answers: is it safe to add long-acting β-2 agonists to inhaled corticosteroids in patients with persistent asthma?
    Townsend L; Madlon-Kay DJ
    J Fam Pract; 2015 Jun; 64(6):370-1. PubMed ID: 26172630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of combination inhaled corticosteroids and long acting beta agonists in the treatment of adult asthma.
    Mayers I ; Damant R
    Issues Emerg Health Technol; 2005 Jun; (68):1-4. PubMed ID: 15966131
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.
    Cowie RL; Boulet LP; Keith PK; Scott-Wilson CA; House KW; Dorinsky PM
    Clin Ther; 2007 Jul; 29(7):1390-402. PubMed ID: 17825690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical safety of long-acting beta2-agonist and inhaled corticosteroid combination therapy in COPD.
    Decramer M; Ferguson G
    COPD; 2006 Aug; 3(3):163-71. PubMed ID: 17240618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety of long-acting β agonists for the treatment of asthma: clearing the air.
    Rodrigo GJ; Castro-Rodríguez JA
    Thorax; 2012 Apr; 67(4):342-9. PubMed ID: 21515554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.